Technological advances enabling remote assessment of cognition in individuals of all ages has been developed over the past two decades. Following the onset of the global COVID-19 pandemic, use of remote cognitive assessment in both research and clinical practice expanded rapidly, often at a pace that eclipsed our ability to evaluate the feasibility, reliability, and validity of measures and methods, as well as to identify and address issues impacting equity and inclusion.

This workshop will bring together a multidisciplinary group of clinician-scientists and patient advocates from academic, regulatory, and pharmaceutical groups to discuss gaps, needs, and opportunities in remote assessment of cognition.  Our aim is to facilitate collaboration and communication among researchers who develop and validate remote assessment measures and those who seek to utilize them for clinical research with people living with neurological conditions and intellectual disabilities.